...
首页> 外文期刊>BMJ (International Edition) >Fortnightly review. Modern drug treatment of chronic asthma
【24h】

Fortnightly review. Modern drug treatment of chronic asthma

机译:

获取原文
           

摘要

The dose of inhaled steroid should be titrated against asthmatic symptoms, peak flow, and usage of β2 agonist drugs. The safest dose of inhaled steroid is the lowest effective maintenance dose producing optimal long term control and quality of life. Adding second line anti-inflammatory controller treatment such as a leukotriene antagonist or theophylline may be an alternative to monotherapy with a high dose of inhaled steroid. If control is inadequate despite optimised anti-inflammatory treatment it is better to add regular treatment with a long acting β2 agonist drug than a short acting one.

著录项

  • 来源
    《BMJ (International Edition)》 |1999年第7180期|380-384|共页
  • 作者

    Lipworth B.J.;

  • 作者单位

    Dept. of Clin. Pharmacol./Therapeut. Ninewells Hosp. and Medical School University of Dundee;

    Dept. Clinical Pharmacol. Therapeut. Ninewells Hospital Medical School University of Dundee;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号